Financial Statements — META

Balance Sheet

(in billions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Cash & Equivalents	11.22	15.46	23.43	35.87	10.19	12.01	28.75	43.89	43.85	32.05	32.31	41.86	36.89	28.79	11.55	14.68	14.31	12.68	14.89	16.60
Short-term Investments	71.23	74.80	57.75	45.72	34.26	35.07	41.48	33.93	27.05	26.04	25.81	23.54	24.23	24.66	25.89	26.06	27.47	27.81	--	--
Accounts Receivable	22.72	21.75	17.47	19.77	17.30	16.56	14.51	16.99	14.70	14.51	13.43	16.17	12.94	12.51	11.04	13.47	11.23	11.53	11.39	14.04
Total Current Assets	119.90	125.48	109.77	108.72	73.12	73.61	90.23	100.05	91.07	76.43	75.33	85.37	78.38	69.56	52.48	59.55	58.32	55.99	59.27	66.67
Property, Plant & Equipment	253.22	225.72	194.78	176.40	160.27	147.04	133.57	121.35	112.16	102.96	98.91	96.59	91.77	87.95	84.16	79.52	73.74	67.59	61.58	57.81
Goodwill	23.42	23.41	24.75	24.53	21.16	20.65	20.65	20.65	20.65	20.65	20.65	20.65	20.67	20.66	20.65	20.31	20.27	20.23	19.92	19.20
Intangible Assets	--	--	--	3.30	2.75	--	--	0.49	0.55	0.56	0.40	0.36	0.39	0.43	0.48	0.52	0.49	0.59	0.55	0.37
Total Non-current Assets*	358.94	324.48	285.49	196.80	230.73	221.13	189.99	136.27	165.34	153.81	147.51	109.88	104.81	100.90	97.06	92.19	87.38	81.72	73.82	69.96
Total Assets	478.84	449.96	395.25	366.02	303.84	294.74	280.21	276.05	256.41	230.24	222.84	229.62	216.27	206.69	184.49	185.73	178.89	169.78	164.22	165.99
Accounts Payable	19.10	15.89	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	63.01	56.38	46.75	41.84	36.96	37.31	33.89	33.60	33.33	27.00	28.10	31.96	30.53	29.92	25.38	27.03	22.69	22.22	21.09	21.14
Long-term Debt	80.92	83.66	58.75	58.74	28.83	28.83	28.83	28.83	28.82	18.39	18.39	18.39	18.38	18.38	9.93	9.92	9.92	--	--	--
Total Non-current Liabilities*	143.44	132.36	104.82	106.94	72.82	62.37	61.29	59.82	58.55	46.47	45.21	44.50	42.87	42.73	34.32	32.99	32.11	21.80	19.90	19.97
Total Liabilities	206.45	188.74	151.57	148.78	109.78	99.67	95.18	93.42	91.88	73.47	73.32	76.46	73.40	72.66	59.70	60.01	54.80	44.01	40.99	41.11
Retained Earnings	165.34	157.84	144.65	121.18	101.58	106.35	101.33	102.51	84.97	81.19	76.79	82.07	75.21	67.98	61.24	64.80	67.06	69.25	67.71	69.76
Total Stockholder Equity	272.39	261.22	243.68	217.24	194.07	195.07	185.03	182.64	164.53	156.76	149.53	153.17	142.87	134.03	124.80	125.71	124.09	125.77	123.23	124.88

← Scroll for more columns →

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Total Revenue	64.60	60.80	56.31	59.89	51.24	47.52	42.31	48.39	40.59	39.07	36.46	40.11	34.15	32.00	28.65	32.17	27.71	28.82	27.91	33.67
Cost of Revenue	13.37	11.33	10.22	10.91	9.21	8.49	7.57	8.84	7.38	7.31	6.64	7.70	6.21	5.95	6.11	8.34	5.72	5.19	6.01	6.35
Gross Profit*	51.23	49.47	46.09	48.99	42.04	39.03	34.74	39.55	33.21	31.76	29.82	32.42	31.00	26.05	22.54	23.83	22.00	23.63	21.90	27.32
Research & Development	20.05	21.66	17.70	17.14	15.14	12.94	12.15	12.18	11.18	10.54	9.98	10.52	9.24	9.34	9.38	9.77	9.17	8.69	7.71	7.05
Selling, General & Admin	14.86	5.61	2.61	3.70	3.51	2.66	2.28	0.76	1.87	3.66	3.46	2.29	2.07	4.16	2.89	3.09	3.38	2.99	2.36	3.31
Total Operating Expenses*	38.24	30.70	23.22	24.24	21.50	18.58	17.19	16.18	15.86	16.92	16.00	16.03	46.16	16.66	15.31	17.43	16.33	15.27	13.38	14.74
Operating Income	12.99	18.77	22.87	24.75	20.54	20.44	17.56	23.37	17.35	14.85	13.82	16.38	13.75	9.39	7.23	6.40	5.66	8.36	8.52	12.59
Pretax Income	13.00	18.76	21.75	25.35	21.66	20.53	18.38	23.55	17.82	15.11	14.18	16.81	14.02	9.29	7.31	6.15	5.58	8.19	8.91	12.70
Tax Provision	3.14	2.91	(5.02)	2.59	18.95	2.20	1.74	2.71	2.13	1.64	1.81	2.79	2.44	1.51	1.60	1.50	1.18	1.50	1.44	2.42
Net Income	9.86	15.85	26.77	22.77	2.71	18.34	16.64	20.84	15.69	13.47	12.37	14.02	11.58	7.79	5.71	4.65	4.39	6.69	7.47	10.29
Basic EPS	3.86	6.23	10.57	9.03	1.08	7.28	6.59	8.24	6.20	5.31	4.86	5.45	4.50	3.03	2.21	1.78	1.64	2.47	2.74	3.71
Diluted EPS	3.83	6.18	10.44	8.87	1.05	7.14	6.43	7.96	6.03	5.16	4.71	5.30	4.39	2.98	2.20	1.77	1.64	2.46	2.72	3.64

← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in billions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Operating Cash Flow	32.78	31.86	32.23	36.21	30.00	25.56	24.03	27.99	24.72	19.37	19.25	19.40	20.40	17.31	14.00	14.51	9.69	12.20	14.08	18.10
Capital Expenditures	33.94	30.12	19.00	21.38	18.83	16.54	12.94	14.43	8.26	8.17	6.40	7.67	6.54	6.22	6.84	9.04	9.38	7.57	5.44	5.37
Free Cash Flow*	(1.16)	1.75	13.23	14.83	11.17	9.02	11.09	13.56	16.47	11.20	12.85	11.74	13.86	11.09	7.16	5.47	0.32	4.62	8.64	12.74
Investing Cash Flow	(30.98)	(49.65)	(33.68)	(34.19)	(21.85)	(25.96)	(20.01)	(21.50)	(8.62)	(8.30)	(8.73)	(6.47)	(6.08)	(5.20)	(6.74)	(7.53)	(9.70)	(6.96)	(4.78)	5.83
Financing Cash Flow	(6.73)	15.97	(6.55)	25.15	(10.05)	(15.98)	(19.49)	(5.46)	(4.37)	(11.18)	(19.77)	(8.40)	(5.87)	5.29	(10.52)	(7.06)	2.15	(6.56)	(10.66)	(21.74)

← Scroll for more columns →

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024
Dividends Per Share	0.53	0.53	0.53	0.53	0.53	0.53	0.50	0.50	0.50	0.50

← Scroll for more columns →